Page 9 - Active Biotech News Today : Breaking News, Live Updates & Top Stories | Vimarsana

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Annual General Meeting of Active Biotech AB PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 19, 2021. Due to the extraordinary situation as a result of the COVID-19 pandemic, the Meeting was carried out through postal voting, without any physical attendance. The following main resolutions were passed. In accordance with the Board of Directors' proposal, it was resolved that no dividend would be paid for the financial year 2020, the Company's accumulated loss shall be carried forward. The members of the Board and the CEO were discharged from liability with respect to...

Annual General Meeting of Active Biotech AB PRESS RELEASE The Annual General Meeting of Active Biotech was held on May 19, 2021. Due to the extraordinary situation as a result of the COVID-19 pandemic, the Meeting was carried out through postal voting, without any physical attendance. The following main resolutions were passed. In accordance with the Board of Directors’ proposal, it was resolved that no dividend would be paid for the financial year 2020, the Company’s accumulated loss shall be carried forward. The members of the Board and the CEO were discharged from liability with respec...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Annual Report 2020 Active Biotech AB (publ) Active BiotechApril 22, 2021 GMT Active Biotech’s Annual Report 2020 is now available for download at www.activebiotech.com. The Annual Report will only be digitally distributed. Helén Tuvesson, CEO, tel. +46 46 19 21 56,  helen.tuvesson@activebiotech.com Hans Kolam, CFO, tel. +46 46 19 20 44, hans.kolam@activebiotech.com ADVERTISEMENT Scheelevägen 22, 223 63 Lund, Sweden Tel. +46 46-19 20 00 This information is information that Active Biotech ...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...